Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Imperial College London
Bristol-Myers Squibb
St. Jude Children's Research Hospital
Duke University
Pediatric Clinical Research Platform
Duke University